EFTA01268401.pdf

From: To: Subject: RE: Cost Basis Date: Tuesday. October 10. 2017 2:26:08 PM OK... That's what they reported to us. Let me know if there's anything else I can support you with. From: Richard Kahn [mailto Sent: Tuesday, October 10, 2017 1:17 PM To: Otoya, Rafael C Cc: Paul Barrett Subject: Re: Cost Basis Cost basis of securities transferred in are as follows: Thank you Purchase Quantity Asset Description Date Cost Ascena Retail Group Inc. (Formerly Dress 1/16/01 70,500 1,500,000 Barn 1.3.11) Foundation Medicine Inc 1/16/14 49,830 1,265,037 Sangamo Therapeutics Inc 5/28/13 50,000 422,214 Richard Kahn HBRK Associates Inc. 575 Lexington Avenue, 4th Floor New York, NY 10022 On Oct 10, 2017, at 2:09 PM, < wrote: SDNY_GM_00012330 CONFIDENTIAL EFTA_00 122979 EFTA01268401 Hello, Richard. I wanted to follow up with you. My understanding is that there may be some questions around cost basis for the assets that you transferred over. How may I support you? <image003.jpg> SDNY_GM_00012331 CONFIDENTIAL EFTA_00122980 EFTA01268402